Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Sep;53(9):1244-9.
doi: 10.1136/gut.2003.034629.

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

W K Leung  1 , S-R Lin, J Y L Ching, K-F To, E K W Ng, F K L Chan, J Y W Lau, J J Y Sung
Affiliations
Clinical Trial

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

W K Leung et al. Gut. 2004 Sep.

Abstract

Background and aims: Gastric intestinal metaplasia (IM) is generally considered to be a precancerous lesion in the gastric carcinogenesis cascade. This study identified the risk factors associated with progression of IM in a randomised control study.

Subjects and methods: A total of 587 Helicobacter pylori infected subjects were randomised to receive a one week course of anti-Helicobacter therapy (omeprazole, amoxicillin, and clarithromycin (OAC)) or placebo. Subjects underwent endoscopy with biopsy at baseline and at five years. Severity of IM was graded according to the updated Sydney classification and progression was defined as worsening of IM scores at five years in either the antrum or corpus, or development of neoplasia. Backward stepwise multiple logistic regression was used to identify independent risk factors associated with IM progression.

Results: Of 435 subjects (220 in the OAC and 215 in the placebo group) available for analysis, 10 developed gastric cancer and three had dysplasia. Overall progression of IM was noted in 52.9% of subjects. Univariate analysis showed that persistent H pylori infection, age >45 years, male subjects, alcohol use, and drinking water from a well were significantly associated with IM progression. Duodenal ulcer and OAC treatment were associated with a reduced risk of histological progression. Progression of IM was more frequent in those with more extensive and more severe IM at baseline. With multiple logistic regression, duodenal ulcer (odds ratio (OR) 0.23 (95% confidence interval (CI) 0.09-0.58)) was found to be an independent protective factor against IM progression. Conversely, persistent H pylori infection (OR 2.13 (95% CI 1.41-3.24)), age >45 years (OR 1.92 (95% CI 1.18-3.11)), alcohol use (OR 1.67 (95% CI 1.07-2.62)), and drinking water from a well (OR 1.74 (95% CI 1.13-2.67)) were independent risk factors associated with IM progression.

Conclusion: Eradication of H pylori is protective against progression of premalignant gastric lesions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Baseline distribution of intestinal metaplasia (IM) in subjects with IM progression. p<0.01.
Figure 2
Figure 2
Severity of antral intestinal metaplasia (IM) at baseline and progression of gastric IM. p = 0.084.
Figure 3
Figure 3
Pattern of gastritis at baseline and progression of gastric intestinal metaplasia (IM). Antrum versus corpus/pangastritis, p = 0.69.
Figure 4
Figure 4
Rate of progression of gastric intestinal metaplasia (IM) according to final Helicobacter pylori (Hp) status after age stratification.
See this image and copyright information in PMC

Comment in

  • Is gastric cancer preventable?
    Correa P. Correa P. Gut. 2004 Sep;53(9):1217-9. doi: 10.1136/gut.2004.039834. Gut. 2004. PMID: 15306570 Free PMC article. Review.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Correa P . Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735–40. - PubMed
    1. Huang JQ, Sridhar S, Chen Y, et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterol 1998;114:1169–79. - PubMed
    1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347–53. - PMC - PubMed
    1. Uemura N , Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–9. - PubMed
    1. Uemura N , Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;6:639–42. - PubMed

Publication types

MeSH terms